Lung Cancer
A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY TO EVALUATE PF-08046054/SGN-PDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLY-TREATED PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC) - Protocol C5851005
- Details
ClinicalTrials.gov ID:
NCT07144280
Diagnosis Type:
NA
USOR Number:
- Address
,
P: